Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Mar;142(3):219-22.
doi: 10.1016/j.clim.2011.12.011. Epub 2011 Dec 30.

Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE

Editorial

Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE

Andras Perl. Clin Immunol. 2012 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram of the metabolic pathways regulating oxidative stress and endosome traffic controlling the recycling of receptor and adaptor proteins between the cell surface and lysosomes. The pentose phosphate pathway (PPP), reduced glutathione (GSH), and nitric oxide (NO) regulate mitochondrial electron transport, the transmembrane potential (Δψm) and the production of reactive oxygen intermediates. The mammalian target of rapamcyin (mTOR) senses Δψm and regulates endosome traffic, protein homeostasis through balancing translation and lysosomal degradation via autophagy. Necrosis-prone T cells release oxidized DNA and HMGB1 which stimulate macrophages, and dendritic cells to produce NO and interferon alpha (IFN-α). Oxidation of cysteine residues and endocytic recycling are proposed to mediate the depletion of the linker for activation of T cells (LAT) in lipid rafts of T lymphocytes in patients with SLE.

Comment on

Similar articles

Cited by

References

    1. Perl A, Fernandez DR, Telarico T, Doherty E, Francis L, Phillips PE. T-cell and B-cell signaling biomarkers and treatment targets in lupus. Curr Opin Rheumatol. 2009;21(5):454–464. - PMC - PubMed
    1. Gergely PJ, Grossman C, Niland B, et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002;46:175–190. - PMC - PubMed
    1. Fernandez DR, Perl A. mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? Discov Med. 2010;9(46):173–178. - PMC - PubMed
    1. Nambiar MP, Fisher CU, Warke VG, et al. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum. 2003;48:1948–1955. - PubMed
    1. Kyttaris VC, Krishnan S, Tsokos GC. Systems biology in systemic lupus erythematosus: Integrating genes, biology and immune function. Autoimmunity. 2006;39(8):705–709. - PubMed

MeSH terms